Pacira Pharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pacira Pharmaceuticals, Inc..The latest application filed is for "manufacturing of bupivacaine multivesicular liposomes".

Company Profile

8.59.63

Pacira Pharmaceuticals, Inc. - San Diego CA US
Pacira Pharmaceuticals, Inc. - Parsippany NJ US
Pacira Pharmaceuticals, Inc.; - US
PACIRA PHARMACEUTICALS, INC - SAN DIEGO CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Manufacturing Of Bupivacaine Multivesicular Liposomes App 20220304932 - Hall; Jeffrey S. ; et al.	2022-09-29
Compositions of bupivacaine multivesicular liposomes Grant 11,452,691 - Hall , et al. September 27, 2	2022-09-27
Compositions Of Bupivacaine Multivesicular Liposomes App 20220280426 - Hall; Jeffrey S. ; et al.	2022-09-08
Treatment Of Hip Pain With Sustained-release Liposomal Anesthetic Compositions App 20220273564 - Slonin; Jonathan H. ; et al.	2022-09-01
Multivesicular Liposome Formulations Of Dexmedetomidine App 20220273568 - Ardekani; Soroush M. ; et al.	2022-09-01
Compositions of bupivacaine multivesicular liposomes Grant 11,426,348 - Hall , et al. August 30, 2	2022-08-30
Manufacturing Of Bupivacaine Multivesicular Liposomes App 20220233447 - Hall; Jeffrey S. ; et al.	2022-07-28
Compositions Of Bupivacaine Multivesicular Liposomes App 20220233442 - Hall; Jeffrey S. ; et al.	2022-07-28
Manufacturing Of Bupivacaine Multivesicular Liposomes App 20220233446 - Hall; Jeffrey S. ; et al.	2022-07-28
Manufacturing Of Bupivacaine Multivesicular Liposomes App 20220233448 - Hall; Jeffrey S. ; et al.	2022-07-28
Treatment Of Hip Pain With Sustained-release Liposomal Anesthetic Compositions App 20220218610 - Slonin; Jonathan H. ; et al.	2022-07-14
Treatment Of Hip Pain With Sustained-release Liposomal Anesthetic Compositions App 20220218613 - Slonin; Jonathan H. ; et al.	2022-07-14
Manufacturing of bupivacaine multivesicular liposomes Grant 11,357,727 - Hall , et al. June 14, 2	2022-06-14
Manufacturing of bupivacaine multivesicular liposomes Grant 11,311,486 - Hall , et al. April 26, 2	2022-04-26
Manufacturing of bupivacaine multivesicular liposomes Grant 11,304,904 - Hall , et al. April 19, 2	2022-04-19
Manufacturing of bupivacaine multivesicular liposomes Grant 11,278,494 - Hall , et al. March 22, 2	2022-03-22
Manufacturing of bupivacaine multivesicular liposomes Grant 11,185,506 - Hall , et al. November 30, 2	2021-11-30
Manufacturing of bupivacaine multivesicular liposomes Grant 11,179,336 - Hall , et al. November 23, 2	2021-11-23
Zinc Meloxicam Complex Microparticles And Anesthetic Formulations And Processes For Making The Same App 20210322316 - Garcia; Louie Daniel ; et al.	2021-10-21
Zinc Meloxicam Complex Microparticle Multivesicular Liposome Formulations And Processes For Making The Same App 20210299047 - Garcia; Louie Daniel ; et al.	2021-09-30
Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same Grant 11,040,011 - Garcia , et al. June 22, 2	2021-06-22
Manufacturing of bupivacaine multivesicular liposomes Grant 11,033,495 - Hall , et al. June 15, 2	2021-06-15
Zinc Meloxicam Complex Microparticle Multivesicular Liposome Formulations And Processes For Making The Same App 20200397699 - Garcia; Louie Daniel ; et al.	2020-12-24
Sustained release formulation of a non-steroidal anti-inflammatory drug Grant 10,729,651 - Garcia , et al.	2020-08-04
Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same Grant 10,709,665 - Garcia , et al.	2020-07-14
Sustained release formulation of a non-steroidal anti-inflammatory drug Grant 10,675,245 - Garcia , et al.	2020-06-09
Sustained release formulation of a non-steroidal anti-inflammatory drug Grant 10,617,642 - Garcia , et al.	2020-04-14
Sustained release formulation of a non-steroidal anti-inflammatory drug Grant 10,610,486 - Garcia , et al.	2020-04-07
Method for formulating large diameter synthetic membrane vesicles Grant 10,398,648 - Schutt , et al. Sep	2019-09-03
Sustained release formulation of a non-steroidal anti-inflammatory drug Grant 10,123,974 - Garcia , et al. November 13, 2	2018-11-13
Method for formulating large diameter synthetic membrane vesicles Grant 10,045,941 - Schutt , et al. August 14, 2	2018-08-14
Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent Grant 10,028,911 - Garcia , et al. July 24, 2	2018-07-24
Zinc Meloxicam Complex Microparticle Multivesicular Liposome Formulations And Processes For Making The Same App 20180161275 - Los; Kathleen Dunne Albright ; et al.	2018-06-14
Sustained release formulation of a non-steroidal anti-inflammatory drug Grant 9,974,744 - Garcia , et al. May 22, 2	2018-05-22
Method For Formulating Large Diameter Synthetic Membrane Vesicles App 20180092847 - Schutt; Ernest George ; et al.	2018-04-05
Method for formulating large diameter synthetic membrane vesicles Grant 9,808,424 - Schutt , et al. November 7, 2	2017-11-07
Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent Grant 9,770,414 - Garcia , et al. September 26, 2	2017-09-26
Method for formulating large diameter synthetic membrane vesicles Grant 9,757,336 - Schutt , et al. September 12, 2	2017-09-12
Method for formulating large diameter synthetic membrane vesicles Grant 9,737,482 - Schutt , et al. August 22, 2	2017-08-22
Method for formulating large diameter synthetic membrane vesicles Grant 9,737,483 - Schutt , et al. August 22, 2	2017-08-22
Method for formulating large diameter synthetic membrane vesicles Grant 9,730,892 - Schutt , et al. August 15, 2	2017-08-15
Method for formulating large diameter synthetic membrane vesicles Grant 9,724,302 - Schutt , et al. August 8, 2	2017-08-08
Production of multivesicular liposomes Grant 9,585,838 - Hartounian , et al. March 7, 2	2017-03-07
Method For Formulating Large Diameter Synthetic Membrane Vesicles App 20160361260 - Schutt; Ernest George ; et al.	2016-12-15
Multivesicular Liposome Formulations Of Tranexamic Acid App 20160206580 - Los; Kathleen D.A. ; et al.	2016-07-21
Sustained-release liposomal anesthetic compositions Grant 9,205,052 - Kim , et al. December 8, 2	2015-12-08
Sustained-release liposomal anesthetic compositions Grant 9,192,575 - Kim , et al. November 24, 2	2015-11-24
Sustained-release liposomal anesthetic compositions Grant 8,834,921 - Kim , et al. September 16, 2	2014-09-16
Production Of Multivesicular Liposomes App 20140004173 - Hartounian; Hartoun ; et al.	2014-01-02
Sustained-release Liposomal Anesthetic Compositions App 20130344132 - Kim; Sinil ; et al.	2013-12-26
Method For Formulating Large Diameter Synthetic Membrane Vesicles App 20130306759 - Schutt; Ernest George ; et al.	2013-11-21
Sustained Release Formulation Of A Non-steroidal Anti-inflammatory Drug App 20130209547 - Garcia; Louie Daniel ; et al.	2013-08-15
Sustained Release Formulation Of A Non-steroidal Anti-inflammatory Drug App 20130209548 - Garcia; Louie Daniel ; et al.	2013-08-15
Method For Formulating Large Diameter Synthetic Membrane Vesicles App 20130195965 - Schutt; Ernest George ; et al.	2013-08-01
Sustained Release Formulation Of A Non-steroidal Anti-inflammatory Drug App 20130189348 - Garcia; Louie Daniel ; et al.	2013-07-25
Sustained Release Formulation Of A Non-steroidal Anti-inflammatory Drug App 20130189350 - Garcia; Louie Daniel ; et al.	2013-07-25
Sustained-release Liposomal Anesthetic Compositions App 20130189349 - Kim; Sinil ; et al.	2013-07-25
Method For Formulating Large Diameter Synthetic Membrane Vesicles App 20130183373 - Schutt; Ernest George ; et al.	2013-07-18
Sustained Release Formulation Of Methotrexate As A Disease-modifying Antirheumatic Drug (dmard) And An Anti-cancer Agent App 20130183370 - Garcia; Louie Daniel ; et al.	2013-07-18
Method For Formulating Large Diameter Synthetic Membrane Vesicles App 20130183375 - Schutt; Ernest George ; et al.	2013-07-18
Sustained Release Formulation Of Methotrexate As A Disease-modifying Antirheumatic Drug (dmard) And An Anti-cancer Agent App 20130183371 - Garcia; Louie Daniel ; et al.	2013-07-18
Method For Formulating Large Diameter Synthetic Membrane Vesicles App 20130183372 - Schutt; Ernest George ; et al.	2013-07-18
Sustained Release Formulation Of A Non-steroidal Anti-inflammatory Drug App 20130183374 - Garcia; Louie Daniel ; et al.	2013-07-18
Method For Formulating Large Diameter Synthetic Membrane Vesicles App 20130177637 - Schutt; Ernest George ; et al.	2013-07-11
Method For Formulating Large Diameter Synthetic Membrane Vesicles App 20130177634 - Schutt; Ernest George ; et al.	2013-07-11
Method For Formulating Large Diameter Synthetic Membrane Vesicles App 20130177636 - Schutt; Ernest George ; et al.	2013-07-11
Method For Formulating Large Diameter Synthetic Membrane Vesicles App 20130177633 - Schutt; Ernest George ; et al.	2013-07-11
Method For Formulating Large Diameter Synthetic Membrane Vesicles App 20130177638 - Schutt; Ernest George ; et al.	2013-07-11
Method For Formulating Large Diameter Synthetic Membrane Vesicles App 20130177635 - Schutt; Ernest George ; et al.	2013-07-11
Sustained-release liposomal anesthetic compositions Grant 8,182,835 - Kim , et al. May 22, 2	2012-05-22
Sustained Release Formulation Of A Non-steroidal Anti-inflammatory Drug App 20120114740 - Garcia; Louie Daniel ; et al.	2012-05-10
Sustained Release Formulation Of Methotrexate As A Disease-modifying Antirheumatic Drug (dmard) And An Anti-cancer Agent App 20110280932 - Garcia; Louie Daniel ; et al.	2011-11-17
Method For Formulating Large Diameter Synthetic Membrane Vesicles App 20110250264 - SCHUTT; ERNEST GEORGE ; et al.	2011-10-13
Hyaluronidase As An Adjuvant For Increasing The Injection Volume And Dispersion Of Large Diameter Synthetic Membrane Vesicles Containing A Therapeutic Agent App 20100305500 - LAMBERT; William ; et al.	2010-12-02

Company Registrations

NCAGE Code	7JZY9	PACIRA PHARMACEUTICALS, INC.
CAGE Code	61QS0	PACIRA PHARMACEUTICALS, INC. FEDERAL
CAGE Code	7JZY9	PACIRA PHARMACEUTICALS, INC.
S.A.M. Registration	61QS0 [783298615]	PACIRA PHARMACEUTICALS, INC.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.